Eiko Lifesciences Ltd
company logo

Eiko Lifesciences Ltd

EIKOLIFESCIENCE Share Price

BSE:540204

53.5

-0.49 (-0.91%)

As on April 10, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

53.99

52.32

195

0.00

10

Fundamentals

76.75Cr

19.24

1.23

0.05

2.78

0%

43.37

About

Eiko Lifesciences Limited was originally incorporated on January 7, 1977, under the name Narendra Investments (Delhi) Limited. Later, Company was renamed from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited with effect from June 24, 2021. Earlier, Company engaged in sale and purchase of shares and securities. At present, Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally. The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India. The key products manufactured by Company are used in pharmaceutical and agrochemical industries with various end use application including corrosion control, photographic chemicals, solvents, and corrosion inhibitors amongst others. In 2022, Company completed the development of new molecules for Agrochemical Intermediates, Polymer Science and Pharma segment. Eiko developed these molecules and launched the same during FY22. The Company diversified into clinical research, development, and innovation within the specialty chemicals, healthcare and medical fields in 2025. It has entered into the container leasing and logistics sector through its subsidiary, EikoVivify Logistics Private Limited in FY 2025.

1977

NameDesignation
Laxmikant KabraChairman & Non Executive Dir.
Bhavesh Dhirajlal TannaNon-Exec & Non-Independent Dir
Rajkumar K BahetiIndependent Non Exe. Director
Kajal Dhanpatraj KothariIndependent Non Exe. Director
Hasti DoshiIndependent Non Exe. Director
Sumukh Prabhakar VartakWhole-time Director
CHINTAN BHARATBHAI DOSHICompany Sec. & Compli. Officer

Eiko Lifesciences Ltd FAQs

How do I Buy Eiko Lifesciences Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Eiko Lifesciences Ltd shares in BlinkX.

What is the Share Price of Eiko Lifesciences Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Eiko Lifesciences Ltd's share price is ₹53.5 as of 2026-04-12.

What is the PE ratio of Eiko Lifesciences Ltd?

close

Eiko Lifesciences Ltd's P/E ratio is 19.24 times as of 2026-04-12.

What is the PB ratio of Eiko Lifesciences Ltd?

close

Eiko Lifesciences Ltd's most recent financial reports indicate a price-to-book ratio of 1.23, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Eiko Lifesciences Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Eiko Lifesciences Ltd's market capitalization is ₹76.75 Cr as on 2026-04-12.

What is the ROE of Eiko Lifesciences Ltd?

close

The current financial records of Eiko Lifesciences Ltd show a 2.75% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Eiko Lifesciences Ltd?

close

According to Eiko Lifesciences Ltd's most recent financial filings, the company has a total asset value of ₹28.45, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Eiko Lifesciences Ltd?

close

The 52-week high/low price of a Eiko Lifesciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Eiko Lifesciences Ltd's 52-week high and low as of 2026-04-12 are ₹65.9 and ₹45.9, respectively.